Search

Search Results

• Semaglutide for the treatment of obesity

  Rafał Oleszczuk, Iga Kozińska, Jordi Gras-Ozimek, Urszula Kozińska, Anna Oleszczuk

  1111-1123

  2022-08-25
• Semaglutide in the Treatment of Diabetes and Associated Obesity

  Rafal Makuch, Alicja Chrościcka , Kamil Gała, Andrzej Czajka, Paweł Lenard, Adam Kucharski, Sara Michalska, Konrad Pilarski, Martyna Dewicka, Alicja Maria Wawrzyniak

  51699

  2024-06-04
• Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  Magdalena Mazurek, Edyta Białowąs, Ewelina Dybała, Iwona Cuber, Artur Aghadi

  123-131

  2023-02-20
• Semaglutide and Other GLP-1 Receptor Agonists as Potential Therapies for Addiction – Mechanisms, Evidence, and Clinical Implications

  Katarzyna Wajda, Wiktoria Mika, Justyna Słowik, Izabela Sieradzka

  66921

  2025-12-12
• The Worldwide Problem of Obesity - Comparison of the Effectiveness of Pharmacological Treatment with Semaglutide and Tirzepatide in Reducing Body Weight

  Karolina Garbino, Katarzyna Brudniak, Magdalena Czyczerska, Antoni Szuścik, Katarzyna Gadżała, Sabina Przygodzka, Maciej Mach, Maciej Rutkiewicz

  58305

  2025-03-07
• Current innovative treatments of obesity

  Damian Wach, Aneta Głaz, Jolanta Wiśniewska, Zuzanna Radziejowska

  227-241

  2023-10-03
• Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review

  Aleksander Jentkiewicz, Esmail Haj Obeid, Jakub Ulrych, Jan Krupa, Maciej Malinowski, Michał Krasowski, Alicja Kalinowska, Wiktoria Pietras, Adrian Kozieł, Zofia Kurek

  57712

  2025-02-06
• Potential benefits of GLP-1 analogues and metformin in patients with osteoarthritis

  Anna Skowronek, Martyna Piekarska, Katarzyna Dąbek, Michał Ochwat, Maria Sudoł, Gabriela Mierzwa, Aleksandra Kajtel, Tomasz Skowronek

  56953

  2025-01-07
• GLP-1 Receptor Agonists in Alcohol Use Disorder: Neurobiological Mechanisms and Therapeutic Potential

  Zuzanna Czach, Dominika Bachurska, Magdalena Ignarska, Justyna Ignarska, Oliwia Grygorczuk, Karolina Krzyżanowska

  66493

  2025-11-17
• Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity

  Magdalena Mazurek, Edyta Białowąs, Ewelina Dybała, Iwona Cuber, Artur Aghadi

  196-205

  2023-02-23
• GLP-1 Receptor Agonists: A New Hope in the Global Fight Against Obesity — Benefits and Health Risks

  Oskar Pastuszek, Konrad Borowski, Maja Radziwon, Emilia Bolesta-Okuniewska, Paweł Michalak, Aleksandra Marchwińska-Pancer, Katarzyna Kopeć, Julia Ceryn, Anna Wicher

  67433

  2026-01-11
• Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity.

  Kamil Pondel, Kinga Kawałko, Krzysztof Bielewicz, Anna Chmura, Anna Karaś

  55-60

  2022-08-30
• Evaluation of the effectiveness and safety of anti-obesity drugs - an update on the current state of knowledge on available and investigational drugs

  Katarzyna Cichoń, Małgorzata Chyćko, Julia Czarnota, Agata Kromer, Magdalena Alicja Zapała, Agnieszka Środoń, Joanna Wilk, Małgorzata Maria Cholewa, Agnieszka Gawryś, Monika Łapaj

  94-112

  2023-05-31
• The Impact of GLP-1 Analogues and Tirzepatide on Female Fertility: Mechanisms, Clinical Evidence, and Implications

  Klaudia Elżbieta Niwińska, Michał Borowski, Julia Aleksandra Leśniak, Natalia Maria Leśniak, Klaudia Martyna Patrzykąt, Anna Maria Zakrzewska, Kinga Popielarska, Julia Agnieszka Michalak, Monika Augustyn, Aleksander Midera

  67444

  2026-01-16
• The multimodal approach to obesity treatment – current pharmacological and surgical methods and lifestyle changes

  Maria Kowalczuk, Justyna Lipińska, Izabela Kopeć, Łukasz Lipiński, Jakub Kamiński, Klaudia Klimczak, Laura Loryś, Marcin Narloch, Stanisław Kasprzak, Karolina Kasprzak

  220-234

  2024-02-14
• Adverse effects of GLP – 1 Receptor Agonists

  Anna Kasprzak, Monika Kułaga, Monika Grzybek, Diana Mazur-Lesińska, Barbara Szostak, Sylwia Wielgosz-Biała, Krzysztof Tyszkiewicz, Borys Łozowski, Małgorzata Kasprzak, Barbara Wilczyńska

  57774

  2025-02-11
• Pharmacological treatment of obesity: an overview of different groups of anti-obesity drugs available in Poland

  Barbara Woch, Dawid Bereza, Katarzyna Sokołowska, Maria Kulak, Igor Moreau, Paulina Polańska, Miriam Lang

  48-59

  2024-02-09
• Challenges and Novelties in the Treatment of Obesity in Adults. A review

  Karolina Kuczapska, Marek Kurowski, Anna Gliwa, Monika Ryglewicz, Dariusz Fabian, Elżbieta Leszczyńska-Knaga, Natalia Jakubczyk, Weronika Rutkowska-Kawalec, Paweł Moczydłowski, Karolina Michalczuk

  57095

  2025-01-07
• Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence

  Natalia Gniaź, Aleksandra Górska, Wiktor Grela, Jagoda Niewiadomska, Daria Furtak, Dawid Tulej, Paulina Głogowska, Alicja Dziedzic, Dominika Marciniuk, Natalia Marko

  56672

  2024-12-07
• The Impact of GLP-1 Receptor Agonists on Women's Reproductive Health: A Review

  Marta Wolszczak, Hanna Wołodkiewicz, Jakub Szmit

  60194

  2025-06-05
• Review of upcoming and currently available anti-obesity drugs in Europe

  Patryk Gryszkiewicz, Jakub Szydło, Jakub Starownik, Jan Wędrychowski, Bernadeta Zabielska

  57-67

  2023-05-15
• An Overview of Modern Strategies for Treating Obesity

  Aleksandra Jędrasek, Marta Barg, Julia Biały-Karbowniczek, Agata Bartela, Klaudia Wojtyła

  49506

  2024-05-14
• Current and upcoming methods of pharmacotherapy of obesity

  Jan Bieniasz, Konrad Dendys, Marcel Kazzi, Michał Puła, Marta Wychota

  241-248

  2023-02-26
• GLP-1 analogs: a comparison of new anti diabetic medications - presenting benefits and risks

  Marika Dębik, Łukasz Szydłowski, Klaudia Żurowska, Artur Bednarski, Aleksandra Krużel, Seweryn Ziajor, Piotr Sajdak, Justyna Tomasik, Marcel Stodolak, Kamil Kłos

  217-239

  2024-02-22